Publicaciones en colaboración con investigadores/as de Istituto per lo Studio e la Prevenzione Oncologica (166)

2024

  1. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

  2. Correction to: Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort (European Journal of Nutrition, (2016), 55, 1, (7-20), 10.1007/s00394-014-0818-5)

    European Journal of Nutrition

2020

  1. Alcohol Consumption and Risk of Parkinson's Disease: Data From a Large Prospective European Cohort

    Movement Disorders, Vol. 35, Núm. 7, pp. 1258-1263

2019

  1. Association of menopausal characteristics and risk of coronary heart disease: A pan-European case-cohort analysis

    International Journal of Epidemiology, Vol. 48, Núm. 4, pp. 1275-1285

  2. CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation

    International Journal of Cancer, Vol. 144, Núm. 8, pp. 1877-1887

  3. Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 144, Núm. 2, pp. 240-250

  4. Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    European Journal of Nutrition, Vol. 58, Núm. 8, pp. 3303-3312

2018

  1. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study

    International Journal of Cancer, Vol. 142, Núm. 7, pp. 1332-1342

  2. Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk: Results from the EPIC cohort

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 790-804

  3. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

    International Journal of Cancer, Vol. 142, Núm. 6, pp. 1189-1201

  4. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort

    International Journal of Cancer, Vol. 143, Núm. 10, pp. 2437-2448

  5. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    International Journal of Cancer, Vol. 142, Núm. 3, pp. 449-459

  6. Inflammatory potential of the diet and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    American Journal of Clinical Nutrition, Vol. 107, Núm. 4, pp. 607-616

  7. KIM-1 as a blood-based marker for early detection of kidney cancer: A prospective nested case–control study

    Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5594-5601

  8. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study

    International Journal of Cancer, Vol. 143, Núm. 4, pp. 801-812

  9. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 143, Núm. 10, pp. 2351-2358

  10. Results from the European prospective investigation into cancer and nutrition link vitamin B6 catabolism and lung cancer risk

    Cancer Research, Vol. 78, Núm. 1, pp. 302-308

2017

  1. Added value of serum hormone measurements in risk prediction models for breast cancer for women not using exogenous hormones: Results from the EPIC cohort

    Clinical Cancer Research, Vol. 23, Núm. 15, pp. 4181-4189

  2. Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort

    International Journal of Cancer, Vol. 140, Núm. 6, pp. 1246-1259

  3. Circulating RANKL and RANKL/OPG and breast cancer risk by ER and PR subtype: Results from the EPIC cohort

    Cancer Prevention Research, Vol. 10, Núm. 9, pp. 525-534